Bristol-Myers says Celgene deal is ‘best path’ as investor opposition mounts

March 6, 2019 admin Business News Comments Off on Bristol-Myers says Celgene deal is ‘best path’ as investor opposition mounts

Bristol-Myers Squibb urged shareholders on Wednesday to support its planned $74 billion takeover of Celgene Corp, as it faces opposition from at least two investors to what could be the largest pharmaceutical deal ever.

…read more

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

Source:: Reuters – Business News